论文信息 - Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study - 字舞流文

Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study

C. Regillo | C. Wykoff | D. Pieramici | A. Khanani | J. Major | Carl J. Danzig | David S. Boyer | Brandon G. Busbee | Brian C. Joondeph | Adam Turpcu | Szilárd Kiss